Pharmacopoeial impurityDesonide USP Related Compound BCat. No. P-D061-002CAS 3103-17-1Family · Pharmaceutical analytical standards
Desonide
A low-potency, non-fluorinated topical corticosteroid, introduced in the United States in 1972: it is used for atopic dermatitis, seborrhoeic dermatitis, contact dermatitis and psoriasis, in children too. This family brings together pharmacopoeial impurities and other impurities.
Did you know?On the US scale of skin corticosteroids, from group I (the most potent) to VII (the mildest), it sits in group VI; in 2006 it also became available as a foam and a hydrogel.
Pharmacopoeial impurityDesonide USP Related Compound BCat. No. P-D061-002CAS 3103-17-1
Impurity1,2-Dihydro DesonideCat. No. P-D061-003CAS 638-93-7
Impurity17-Carboxy DesonideCat. No. P-D061-004CAS 117782-94-2
ImpurityBromodesonideCat. No. P-D061-005CAS 39672-77-0
Impuritydelta-14-DesonideCat. No. P-D061-006CAS 131918-67-7
ImpurityDesglycolaldehyde DesonideCat. No. P-D061-007CAS 117782-95-3
ImpurityDesonide 21-Aldehyde HydrateCat. No. P-D061-008
ImpurityDesonide glyoxalCat. No. P-D061-009CAS 57171-18-3
ImpurityDesonide Impurity 1Cat. No. P-D061-010
ImpurityDesonide Impurity 2Cat. No. P-D061-011CAS 3754-07-2
ImpurityDesonide Impurity 3Cat. No. P-D061-012CAS 2672-21-1
ImpurityDesonide Impurity 4Cat. No. P-D061-014
ImpurityDesonide Impurity 6Cat. No. P-D061-017CAS 910299-73-9
ImpurityDesonide Impurity 7Cat. No. P-D061-018CAS 910299-72-8
ImpurityDesonide 9,11-EpoxideCat. No. P-D061-019CAS 39672-75-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.